BioNexus Gene Lab (BGLC) Competitors $5.23 -0.03 (-0.57%) Closing price 04:00 PM EasternExtended Trading$5.24 +0.01 (+0.29%) As of 05:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BGLC vs. BMGL, CCM, MRAI, MGRX, BRTX, KDLY, ACON, NIVF, DHAC, and BACKShould you be buying BioNexus Gene Lab stock or one of its competitors? The main competitors of BioNexus Gene Lab include Basel Medical Group (BMGL), Concord Medical Services (CCM), Marpai (MRAI), Mangoceuticals (MGRX), Biorestorative Therapies (BRTX), Kindly MD (KDLY), Aclarion (ACON), NewGenIvf Group (NIVF), Digital Health Acquisition (DHAC), and IMAC (BACK). These companies are all part of the "healthcare" industry. BioNexus Gene Lab vs. Its Competitors Basel Medical Group Concord Medical Services Marpai Mangoceuticals Biorestorative Therapies Kindly MD Aclarion NewGenIvf Group Digital Health Acquisition IMAC Basel Medical Group (NASDAQ:BMGL) and BioNexus Gene Lab (NASDAQ:BGLC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings. Do insiders & institutionals believe in BMGL or BGLC? 18.9% of BioNexus Gene Lab shares are owned by institutional investors. 0.7% of BioNexus Gene Lab shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has higher earnings and valuation, BMGL or BGLC? Basel Medical Group has higher earnings, but lower revenue than BioNexus Gene Lab. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBasel Medical GroupN/AN/AN/AN/AN/ABioNexus Gene Lab$9.55M0.98-$1.60MN/AN/A Do analysts prefer BMGL or BGLC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00BioNexus Gene Lab 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is BMGL or BGLC more profitable? Basel Medical Group has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -30.70%. Basel Medical Group's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets Basel Medical GroupN/A N/A N/A BioNexus Gene Lab -30.70%-35.54%-29.08% Does the media favor BMGL or BGLC? In the previous week, BioNexus Gene Lab had 1 more articles in the media than Basel Medical Group. MarketBeat recorded 1 mentions for BioNexus Gene Lab and 0 mentions for Basel Medical Group. Basel Medical Group's average media sentiment score of 0.00 beat BioNexus Gene Lab's score of -0.01 indicating that Basel Medical Group is being referred to more favorably in the media. Company Overall Sentiment Basel Medical Group Neutral BioNexus Gene Lab Neutral SummaryBasel Medical Group and BioNexus Gene Lab tied by winning 4 of the 8 factors compared between the two stocks. Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BGLC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGLC vs. The Competition Export to ExcelMetricBioNexus Gene LabMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.40M$8.15B$6.10B$10.53BDividend YieldN/A2.81%5.51%4.67%P/E RatioN/A73.0985.6826.86Price / Sales0.9838.70583.23185.42Price / CashN/A23.0126.3031.10Price / Book1.136.8913.256.72Net Income-$1.60M$247.60M$3.30B$276.44M7 Day Performance-4.39%1.68%4.70%3.13%1 Month Performance3.77%1.69%8.43%10.21%1 Year Performance23.64%11.12%88.01%40.35% BioNexus Gene Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGLCBioNexus Gene Lab0.0849 of 5 stars$5.23-0.6%N/A+24.7%$9.40M$9.55M0.0030BMGLBasel Medical GroupN/A$1.82+1.7%N/AN/A$33.03MN/A0.0036CCMConcord Medical Services1.328 of 5 stars$6.13-6.7%N/A-18.4%$28.52M$52.60M0.00970Gap DownMRAIMarpaiN/A$1.36+3.8%N/A+170.0%$24.90M$34.87M-0.52150News CoverageGap UpHigh Trading VolumeMGRXMangoceuticals0.7079 of 5 stars$2.19+3.8%N/A-94.8%$22.23M$620K-0.573BRTXBiorestorative Therapies1.6074 of 5 stars$1.45flatN/A-6.0%$11.57M$400K-1.147News CoverageGap UpKDLYKindly MDN/A$1.17+1.7%N/A+9.4%$7.05M$2.47M-1.52N/AGap UpHigh Trading VolumeACONAclarion2.0398 of 5 stars$7.50-1.7%$11,758.50+156,680.0%-99.5%$4.44M$50K0.007News CoveragePositive NewsNIVFNewGenIvf GroupN/A$1.79-1.1%N/A-99.7%$3.90M$5.43M0.00N/ANews CoveragePositive NewsDHACDigital Health AcquisitionN/A$0.63-1.4%N/A-49.0%$2.26MN/A0.002,021BACKIMACN/A$0.07-2.8%N/A-93.1%$145K$72.05K0.00180Positive NewsGap Up Related Companies and Tools Related Companies BMGL Alternatives CCM Alternatives MRAI Alternatives MGRX Alternatives BRTX Alternatives KDLY Alternatives ACON Alternatives NIVF Alternatives DHAC Alternatives BACK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGLC) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
